FDA Adverse Event Malfunction Summary report: N

SOLOGRIP III HANDPIECE

MDR report key: 3165275 · Received June 12, 2013

Report

Report Number
2950727-2013-00007
Event Type
Malfunction
Date Received
June 12, 2013
Date of Event
December 19, 2012
Report Date
June 4, 2013
Manufacturer
CARDIOGENESIS CORPORATION
Product Code
MNO
PMA / PMN Number
P970029
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE REPORT, THE SURGEON WAS ON HIS 5TH CHANNEL WITH THE SOLOGRIP III HANDPIECE WHEN THE FIBER FAILED TO GO THROUGH THE MYOCARDIUM. ANOTHER HANDPIECE WAS USED AND IT REPORTEDLY FAILED AFTER 4 CHANNELS WERE CREATED. NO ONE WAS INJURED AND THERE WAS NO IMPACT TO THE PATIENT. THIS REPORT REPRESENTS THE FIRST OF THE TWO HANDPIECES. THE HANDPIECES WERE NOT RETURNED AND SERIAL NUMBERS WERE NOT PROVIDED. A MANUFACTURING RECORDS REVIEW OF POSSIBLE UNITS USED IN THE SURGERY WAS PERFORMED TO DETERMINE IF THERE WERE ISSUES DURING MANUFACTURING THAT COULD BE ATTRIBUTED TO THE REPORTED EVENT. THERE WERE NO ISSUES DURING MANUFACTURING NOTED IN THE DEVICE HISTORY RECORD FOR ANY OF THE LOTS POSSIBLY AVAILABLE AT THE TIME OF SURGERY. SINCE THE DEVICES WERE NOT RETURNED, AN EVALUATION OF THE HANDPIECES COULD NOT BE PERFORMED. THE CAUSE OF THE DAMAGE REPORTED IS MOST LIKELY FROM BENDING THE STRAIN RELIEF TUBING WHILE MOVING THE THUMBSLIDE, RESULTING IN RESTRICTION OF THE FIBER AND BUCKLING OF THE FIBER WITHIN IN THE HANDPIECE. WHEN THE LASER IS PULSED EXTREME HEAT IS PRODUCED RESULTING IN CHARRING OF THE FIBER. AS A CORRECTIVE ACTION, AN ATTENTION LABEL IS NOW ADHERED TO THE DEVICE PACKAGING. THE LABEL PROVIDES ADDITIONAL HANDLING INSTRUCTION DESIGNED TO PREVENT A RECURRENCE OF THIS TYPE OF EVENT. AT THE TIME THE REPORT WAS RECEIVED, CARDIOGENESIS DID NOT BELIEVE THE EVENT MET THE REPORTING REQUIREMENTS OF 21 CFR 803. THE EVENT DID NOT INVOLVE INJURY TO THE PATIENT, USER, OR ANY OTHER INDIVIDUAL. FURTHERMORE, THE EVENT WAS CONSIDERED TO BE OF A NATURE SUCH THAT A RECURRENCE COULD NOT REASONABLY BE EXPECTED TO CAUSE INJURY OR DEATH BECAUSE NO POTENTIALLY HARMFUL CONDITIONS WERE REPORTED.

Description of Event or Problem · 1

ACCORDING TO THE REPORT, THE SURGEON WAS ON HIS 5TH CHANNEL WITH THE SOLOGRIP III HANDPIECE WHEN THE FIBER FAILED TO GO THROUGH THE MYOCARDIUM. ANOTHER HANDPIECE WAS USED AND IT REPORTEDLY FAILED AFTER 4 CHANNELS WERE CREATED. NO ONE WAS INJURED AND THERE WAS NO IMPACT TO THE PATIENT. THIS REPORT REPRESENTS THE FIRST OF THE TWO HANDPIECES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
266473 SOLOGRIP III HANDPIECE TRANSMYOCARDIAL LASER REVASCULARIZATION HANDPIECE MNO CARDIOGENESIS CORPORATION HP-SG3

Patients

Seq Age Sex Outcome Treatment
1